Search

everythinglearnresearchcommunity

for

Search:↓

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

Cannabidiol shows promise as an effective treatment for acne.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Plant-derived extracellular vesicles show promise for treating diseases like cancer and inflammation.

Biodegradable polymers can improve cannabinoid delivery but need more clinical trials.

Stinging nettle has compounds that help with joint pain, arthritis, and prostate issues.

Some vitamins and minerals are important for preventing hair loss, but treating hair loss with them without a known deficiency is not proven effective.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

Hypothyroidism may worsen metabolic problems like insulin resistance and obesity in women with PCOS.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

People with a family history of hair loss are more likely to experience it, and the severity of hair loss is linked to insulin resistance. The connection between early hair loss and oxidative stress needs more investigation.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Women with PCOS often have sleep problems, including sleep apnea, which are linked to obesity and depression.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Higher myostatin and insulin resistance are linked to androgenetic alopecia.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Women with more body hair tend to have thicker belly fat and more metabolic health issues.

Acne patients have higher levels of mTOR in their skin, which could be linked to future metabolic disease.

Depression in women with Polycystic Ovarian Syndrome (PCOS) is linked to insulin resistance and hyperandrogenism, and managing these can help reduce depression. Lifestyle changes and Cognitive Behavioral Therapy can be effective treatments.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.